Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional RegistryWenhua Liang, Jianxing He, Jiaxi He et al.|Journal of Clinical Oncology|2017Cited by 358
Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based StudyChenyang Dai, Jianxing He, Jianfei Shen et al.|Journal of Clinical Oncology|2016Cited by 245
The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomyShugeng Gao, Yousheng Mao, Zhongheng Zhang et al.|Journal of Thoracic Disease|2017Cited by 58
International expert consensus on the management of bleeding during VATS lung surgeryLunxu Liu, Alessandro Brunelli, Qun Wang et al.|Annals of Translational Medicine|2019Cited by 42
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory studyHaoran Xia, Gening Jiang, Han Zhang et al.|Signal Transduction and Targeted Therapy|2024Cited by 30